Tennessee 2023-2024 Regular Session

Tennessee Senate Bill SB2638

Caption

AN ACT to amend Tennessee Code Annotated, Title 47; Title 53 and Title 68, relative to pharmaceutical advertisements.

Impact

The enactment of SB2638 would align the regulation of pharmaceutical advertising with the provisions of the Tennessee Consumer Protection Act of 1977. By classifying violations of this new provision as unfair or deceptive acts affecting trade or commerce, the bill enables the Attorney General to take enforcement actions against those breaching these advertising regulations. Consequently, this could result in a stricter and more controlled environment for pharmaceutical marketing in Tennessee, where companies may need to adapt their marketing strategies significantly to comply with the new legal framework.

Summary

Senate Bill 2638 aims to amend the Tennessee Code Annotated, specifically targeting the area of pharmaceutical advertisements. The bill formally establishes prohibitions on the broadcasting, displaying, or dissemination of pharmaceutical advertisements to consumers, thus significantly restricting the ways in which pharmaceutical companies can promote their products directly to the public. The bill recognizes various forms of media, including newspapers, online platforms, and television, as channels for these advertisements, aiming to provide comprehensive coverage against potentially deceptive practices in the marketing of prescription drugs.

Contention

Potential points of contention surrounding SB2638 include concerns from industry stakeholders regarding the impact on marketing freedoms and the implications for public awareness about prescription medications. Critics might argue that such restrictions could limit valuable information that consumers need to make informed decisions about their health and medication options. On the other hand, proponents see these regulations as essential for protecting consumers from misleading advertisements that often embellish the efficacy and minimize the risks associated with prescription drugs.

Companion Bills

TN HB2367

Crossfiled AN ACT to amend Tennessee Code Annotated, Title 47; Title 53 and Title 68, relative to pharmaceutical advertisements.

Previously Filed As

TN HB2367

AN ACT to amend Tennessee Code Annotated, Title 47; Title 53 and Title 68, relative to pharmaceutical advertisements.

TN SB1643

AN ACT to amend Tennessee Code Annotated, Title 37; Title 47, Chapter 18 and Title 68, relative to age verification for certain material.

TN HB1614

AN ACT to amend Tennessee Code Annotated, Title 39, Chapter 17 and Title 47, relative to the Protect Tennessee Minors Act.

TN SB1792

AN ACT to amend Tennessee Code Annotated, Title 39, Chapter 17 and Title 47, relative to the Protect Tennessee Minors Act.

TN SB1720

AN ACT to amend Tennessee Code Annotated, Title 47; Title 63 and Title 68, relative to healthcare practice.

TN HB2451

AN ACT to amend Tennessee Code Annotated, Title 47; Title 63 and Title 68, relative to healthcare practice.

TN SB0073

AN ACT to amend Tennessee Code Annotated, Title 4; Title 12; Title 43; Title 45; Title 47; Title 48; Title 50; Title 61; Title 66 and Title 67, relative to commerce.

TN HB1181

AN ACT to amend Tennessee Code Annotated, Title 4; Title 12; Title 43; Title 45; Title 47; Title 48; Title 50; Title 61; Title 66 and Title 67, relative to commerce.

TN SB1031

AN ACT to amend Tennessee Code Annotated, Title 53 and Title 68, relative to relative to drug labels.

TN HB1157

AN ACT to amend Tennessee Code Annotated, Title 53 and Title 68, relative to relative to drug labels.

Similar Bills

No similar bills found.